« Back
Home /
LY2090314

LY2090314

Item no.	V0223-25mg
Manufacturer	InvivoChem LLC
CASRN	603288-22-8
Amount	25 mg
Quantity options	100 mg 10 mg 250 mg 500 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Biochemicals
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Description	InvivoChem Cat #:V0223CAS #:603288-22-8Purity >=98% Description: LY2090314 (LY-2090314) is a novel and potent GSK-3 (glycogen synthase kinase-3) inhibitor for GSK-3alpha/beta with potential antitumor activity. It inhibits GSK-3alpha/beta with an IC50 of 1.5 nM/0.9 nM. LY2090314 may also improve the antitumor efficacy of platinum-based chemotherapies. Description: Description: LY2090314 (LY-2090314) is a novel and potent GSK-3 (glycogen synthase kinase-3) inhibitor for GSK-3alpha/beta with potential antitumor activity. It inhibits GSK-3alpha/beta with an IC50 of 1.5 nM/0.9 nM. LY2090314 may also improve the antitumor efficacy of platinum-based chemotherapies.LY-2090314GSK-3alpha/beta References:Brail LH, et al. J Clin Oncol, 2011, 29, abstr 3030. References:References:

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 25 mg

available

Delivery expected until 9/4/2025

Express Delivery: Save 2 days

Compare

Add to wishlist

Get an offer